Addressing Mental Health Stigma in Pharmacy Education Reviewing Educational Interventions and Outcomes
Abstract
Mental health stigma remains a significant barrier to optimal patient care, and its impact is felt across various healthcare professions, including pharmacy. This review article critically examines the landscape of mental health stigma in pharmacy education, focusing on innovative educational interventions designed to mitigate stigma and enhance the preparedness of future pharmacists. Drawing from a comprehensive analysis of the literature, this review explores diverse approaches such as targeted curricular enhancements, simulation-based training, and experiential learning opportunities. Additionally, the article evaluates the outcomes of these interventions, including changes in student attitudes, knowledge, and behavior towards individuals with mental health conditions.
How to cite this article:
Patel S, Patel K. Addressing Mental Health Stigma
in Pharmacy Education: Reviewing Educational
Interventions and Outcomes. Int J Adv Res Pharm
Edu 2023; 5(2): 1-4.
References
Corrigan, P. W., Druss, B. G., & Perlick, D. A. (2014). The Impact of Mental Illness Stigma on Seeking and Participating in Mental Health Care. Psychological Science in the Public Interest, 15(2), 37–70.
Henderson, C., Noblett, J., Parke, H., Clement, S., Caffrey, A., Gale-Grant, O., ... & Thornicroft, G. (2014). Mental health-related stigma in health care and mental health-care settings. The Lancet Psychiatry, 1(6), 467- 482.
Clement, S., Schauman, O., Graham, T., Maggioni, F., Evans-Lacko, S., Bezborodovs, N., ... & Thornicroft, G. (2015). What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychological Medicine, 45(1), 11-27.
Patten, S. B., Remillard, A., Phillips, L., Modgill, G., Szeto, A. C., & Kassam, A. (2012). Effectiveness of contact-based education for reducing mental illnessrelated stigma in pharmacy students. BMC Medical Education, 12(1), 120.
Reavley, N. J., & Jorm, A. F. (2011). Stigmatizing attitudes towards people with mental disorders: Changes in Australia over 8 years. Psychiatry Research, 186(2-3), 267-272.
O’Connor, K., Pirkis, J., Cox, G. R., & The International COVID-19 Suicide Prevention Research Collaboration. (2020). The International COVID-19 Suicide Prevention Research Collaboration: A protocol for a collaborative research project. International Journal of Mental Health
Systems, 14(1), 1-6.
Knaak, S., & Patten, S. (2016). A grounded theory model for reducing stigma in health professionals in Canada. Acta Psychiatrica Scandinavica, 134(Suppl. 446), 53-62.
Stone, D. M., Holland, K. M., Bartholow, B., Crosby, A. E., Jack, S. P. D., Wilkins, N., ... & Boscoe, F. P. (2021). Deciphering suicide and other manners of death associated with drug intoxication. Drug and Alcohol Dependence, 218, 108395.
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2020). Practitioner review: Shared decision making in child mental health. Journal of Child Psychology and Psychiatry, 61(5), 480-491.
Rusch, N., Evans-Lacko, S. E., Henderson, C., Flach, C., & Thornicroft, G. (2011). Knowledge and attitudes as predictors of intentions to seek help for and disclose a mental illness. Psychiatric Services, 62(6), 675-678.
Kassam, A., Glozier, N., Leese, M., Loughran, J., Thornicroft, G., & Henderson, C. (2010). Development and responsiveness of a scale to measure clinicians’ attitudes to people with mental illness (medical student version). Acta Psychiatrica Scandinavica, 122(2), 153- 161.
Ross, A. M., & MacLeod, C. (2015). Stress, anxiety and depression: Understanding the benzodiazepine pathway. Journal of Pharmacy Practice and Research, 45(4), 462-466.
